Rajesh Jain, joint managing director, Panacea Biotec expects the USFDA approval for the collaborated drug by next year to early-2016.
first published: Dec 19, 2014 03:00 pm
A collection of the most-viewed Moneycontrol videos.
Nifty Poised To Clock Weekly Gains; PSU Banks & Metals Star Performers This Week| Closing Bell Live
WeWork India’s Rs 3,000 Cr IPO Kicks Off| MD & CEO Karan Virwani On Future Roadmap| IPO Watch Live
Nifty Set To End Week Strong As Bulls Charge Towards 25,000 | Opening Bell Live
Nifty Zooms Past 24,800 As RBI Policy Revives Festive Cheer| Banks Top Gainers| Closing Bell Live
You are already a Moneycontrol Pro user.